Unique ID issued by UMIN | UMIN000015895 |
---|---|
Receipt number | R000018502 |
Scientific Title | Drug Use-results survey for Simponi 50mg |
Date of disclosure of the study information | 2014/12/15 |
Last modified on | 2019/03/06 10:53:51 |
Drug Use-results survey for Simponi 50mg
Drug Use-results survey for Simponi 50mg
Drug Use-results survey for Simponi 50mg
Drug Use-results survey for Simponi 50mg
Japan |
Rheumatoid Arthritis
Clinical immunology | Orthopedics |
Others
NO
Confirm the safety and efficacy of Simponi in the patients with Rheumatoid arthritis
Safety,Efficacy
Safety (Adverse Drug Reaction)
Effectiveness (Disease Activity Score 28, Visual Analog Scale)
Observational
Not applicable |
Not applicable |
Male and Female
Patients with rheumatoid arthritis who are treated with Simponi
NA
3000
1st name | |
Middle name | |
Last name | Toshiya Kato |
Janssen Pharmaceutical K.K.
Safety Risk Management Dept.
5-2, Nishi-Kanda 3chome, Chiyoda-ku, Tokyo
03-4411-5017
tkato1@its.jnj.com
1st name | |
Middle name | |
Last name | Akiko Yamamoto |
Janssen Pharmaceutical K.K.
Safety Risk Management Dept.
5-2, Nishi-Kanda 3chome, Chiyoda-ku, Tokyo
03-4411-5173
ayamamot@its.jnj.com
Janssen Pharmaceutical K.K.
Janssen Pharmaceutical K.K.
Profit organization
NO
2014 | Year | 12 | Month | 15 | Day |
Published
Completed
2011 | Year | 08 | Month | 05 | Day |
2011 | Year | 09 | Month | 16 | Day |
Prospective study
2014 | Year | 12 | Month | 10 | Day |
2019 | Year | 03 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018502